West Pharmaceutical Services, Inc.
WST Healthcare Medical Instruments & Supplies
West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024. In the quarter to June 2026, revenue grew 13.8%, EPS grew 19.2%, free cash flow fell 20.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
Follow WST
West Pharmaceutical Services, Inc. (WST) Shares outstanding
West Pharmaceutical Services, Inc.'s shares outstanding at the end of fiscal 2025 was $72.7M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $71.3M. Over the past ten years it has ranged from $72.7M (fiscal 2025) to $76.3M (fiscal 2021) — the current reading is the lowest in ten years. West Pharmaceutical Services, Inc. ranks 20th of 50 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $72.7M | (1.36%) |
| FY2024 | $73.7M | (2.12%) |
| FY2023 | $75.3M | (0.66%) |
| FY2022 | $75.8M | (0.66%) |
| FY2021 | $76.3M | 0.66% |
| FY2020 | $75.8M | 0.53% |
| FY2019 | $75.4M | 0.00% |
| FY2018 | $75.4M | (0.53%) |
| FY2017 | $75.8M | 1.07% |
| FY2016 | $75.0M | 1.63% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $71.3M | (1.52%) |
| Mar 2026 | $72.4M | (0.41%) |
| Dec 2025 | $72.7M | 0.14% |
| Sep 2025 | $72.6M | 0.14% |
| 42 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| MDLN Medline Inc. compare | $861.0M |
| BAX Baxter International Inc. compare | $518.0M |
| ALC Alcon compare | $488.7M |
| BDX Becton, Dickinson and Company compare | $275.2M |
| COO The Cooper Companies, Inc. compare | $193.4M |
| SOLV Solventum Corporation compare | $173.3M |
| RMD ResMed Inc. compare | $146.1M |
| WST West Pharmaceutical Services, Inc. | $71.3M |
| RGEN Repligen Corporation compare | $56.6M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on WST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement